TITLE

Veteran Subjects Willingness to Participate in Schizophrenia Clinical Trials

AUTHOR(S)
Hoblyn, J.; Rosenheck, R.; Leatherman, S.; Weil, L.; Lew, Robert
PUB. DATE
June 2013
SOURCE
Psychiatric Quarterly;Jun2013, Vol. 84 Issue 2, p209
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Predictive characteristics of subjects agreeing to be randomized into clinical trials for the treatment of schizophrenia and schizoaffective disorder have been little studied. In this study, we used data from the recruitment phase of a randomized trial that compared long acting injectable (LAI) risperidone to oral antipsychotic medications. Basic socio-demographic and clinical data were gathered from eligible patients and clinicians at the time of screening for trial entry. Bivariate comparisons and multivariate logistic regression were used to compare those who agreed to participate and those who refused. Altogether 446 veterans were eligible on preliminary screening, of these 382 (86 %) agreed to participate and 64 (14 %) declined. Eligible patients who agreed to be randomized were more willing to change medications without regard to their level of satisfaction with their current medication. Subjects reported as currently taking LAI medication and taking risperidone, in particular, were more likely to agree to participate. Factors that did not significantly predict participation included age, years on current medication, reported medication compliance, race, and gender. Veterans with schizophrenia or schizoaffective disorder who were actually more satisfied with their current medications and who were currently taking the experimental agent were more likely to agree to participate in this randomized clinical trial in contrast to expectations that individuals who are unsatisfied with their current treatment would be more likely to enroll in such studies.
ACCESSION #
87621541

 

Related Articles

  • Incidence of psychotic disorders in immigrant groups to The Netherlands. Selten, J.-P.; Veen, N.; Feller, W.; Blom, J. D.; Schols, D.; Camoenië, W.; Oolders, J.; van der Velden, M.; Hoek, H. W.; Rivero, V. M. Vladár; van der Graaf, Y.; Kahn, R. // British Journal of Psychiatry;Apr2001, Vol. 178, p367 

    Background Previous reports on the incidence of schizophrenia in immigrant groups to The Netherlands were based on hospital data. Aims To compare the incidence of psychotic disorders in the immigrant groups to that in natives. Method Two-year first-contact incidence study in The Hague. Results...

  • Untreated illness and outcome of psychosis. Clarke, Mary; Whitty, Peter; Browne, Stephen; McTigue, Orfhlaith; Kamali, Moayyad; Gervin, Maurice; Kinsella, Anthony; Waddington, John L.; Larkin, Conal; O'Callaghan, Eadbhard // British Journal of Psychiatry;Sep2006, Vol. 189, p235 

    Background There has been controversy as to whether early intervention in psychosis can improve the outcome of the disorder. Aims To establish if there is an association between duration of untreated psychosis and the 4-year outcome of persons with a first episode of psychosis. Method...

  • Symptom Presentation in Patients with Acute Schizophernia: Comparison in Three Major Malysian Ethnic Groups. Ainsah, O.; Nurulwafa, H.; Osman, C. B. // Hong Kong Journal of Psychiatry;2008, Vol. 18 Issue 2, p62 

    Objective: This cross-sectional study was conducted to examine the difference in presenting symptoms among Malay, Chinese, and Indian patients with schizophrenia, who were admitted to the psychiatric wards of Hospital Kuala Lumpur, Malaysia. Participants and Methods: This study was conducted...

  • Effect of socioeconomic status and parents’ education at birth on risk of schizophrenia in offspring. Corcoran, Cheryl; Perrin, Mary; Harlap, Susan; Deutsch, Lisa; Fennig, Shmuel; Manor, Orly; Nahon, Daniella; Kimhy, David; Malaspina, Dolores; Susser, Ezra // Social Psychiatry & Psychiatric Epidemiology;Apr2009, Vol. 44 Issue 4, p265 

    Although it is known that schizophrenia is associated with social class, controversy exists as to the nature of this association. The authors studied the incidence of schizophrenia in relation to social class at birth in a population-based cohort of 88,829 offspring born in Jerusalem in...

  • Distribution of symptom dimensions across Kraepelinian divisions. Dikeos, Dimitris G.; Wickham, Harvey; McDonald, Colm; Walshe, Muriel; Sigmundsson, Thordur; Bramon, Elvira; Grech, Anton; Toulopoulou, Timothea; Murray, Robin; Sham, Pak C. // British Journal of Psychiatry;Oct2006, Vol. 189, p346 

    Background: Dimensional structures are established for many psychiatric diagnoses, but dimensions have not been compared between diagnostic groups.Aims: To examine the structure of dimensions in psychosis, to analyse their correlations with disease characteristics and...

  • Schizophrenia study finds cognitive deficits significantly impair decisionmaking capacity.  // Biomedical Market Newsletter;8/12/2011, Vol. 21, p542 

    The article offers information on the study regarding the capacity of schizophrenia patients to consent with clinical research studies in which the study focused on impairment due to the associated psychotic symptoms.

  • Schizophrenia and Measles ... What's Up? Buckley, Peter F. // Clinical Schizophrenia & Related Psychoses;Winter2016, Vol. 9 Issue 4, p166 

    A letter to the editor is presented in response to the article "The Enduring Search-for the Koplik Spots of Psychosis" by P. Fusar-Poli and colleagues in the 2015 issue.

  • Bipolar I disorder with mood-incongruent psychotic symptoms. Marneros, Andreas; Röttig, Stephan; Röttig, Dörthe; Tscharntke, Andrea; Brieger, Peter // European Archives of Psychiatry & Clinical Neuroscience;Apr2009, Vol. 259 Issue 3, 4 p131 

    The purpose of this paper is to demonstrate similarities and differences between bipolar I patients with and without mood-incongruent symptoms (MIS) over a long period of time, independently of longitudinal syndromatic constellations. The Halle bipolarity longitudinal study (HABILOS)...

  • Influential Ideas and Experimental Progress in Schizophrenia Genetic Research. Sanders, Alan R.; Gejman, Pablo V. // JAMA: Journal of the American Medical Association;6/13/2001, Vol. 285 Issue 22, p2831 

    Focuses on schizophrenia. Symptoms, which include disruptions of thinking, perception, mood and behavior; Background of the disease; Suggestion that the disease may be inherited; Various methods of studying the disease; Hope that the isolation of susceptibility genes for schizophrenia can be...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics